$5.40+0.61 (+12.73%)
Butterfly Network, Inc.
Butterfly Network, Inc. in the Healthcare sector is trading at $5.40. The stock is currently near its 52-week high of $5.72, remaining 78.8% above its 200-day moving average. Technical signals show neutral RSI of 67 and bearish MACD signal, explaining why BFLY maintains its current momentum and trend strength. The Whystock Score of 75/100 reflects a high-conviction bullish alignment.
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Butterfly Network, Inc. develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. The company offers Butterfly iQ+ and iQ3 ultrasound devices that can perform whole-body imaging on a single hand...
Butterfly Network (NYSE:BFLY) reported first-quarter 2026 results that management said reflected continued momentum across its core point-of-care ultrasound (POCUS) business and its growing Butterfly Embedded segment, while also highlighting new regulatory and commercial milestones tied to its artif
Butterfly Network (BFLY) delivered earnings and revenue surprises of +25.00% and +2.04%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
A few weeks ago, a research paper out of MIT (the college) crossed my desk that most investors would have ignored.It was about worms. Specifically, it was about a team that had successfully mapped the entire brain of a microscopic worm — every neuron, every connection. Then it laid out what it would take to scale that process from a worm… to a mouse… and eventually, to a human.InvestorPlace - Stock Market News, Stock Advice & Trading Tips Now, here’s where things get interesting for us. For deca
In March 2026, Butterfly Network announced it had secured FDA approval for its AI-powered handheld ultrasound tool to estimate gestational age, aimed at supporting faster decisions in emergency and rural care settings. This regulatory milestone reinforces Butterfly's effort to pair Ultrasound-on-Chip hardware with AI and cloud software to broaden access to maternal healthcare, particularly in underserved regions. We will now examine how FDA clearance for Butterfly's gestational-age AI tool...
Butterfly Network Inc (NYSE:BFLY) is among the best medical AI stocks to buy now. The stock has soared more than 90% over the past six months. On March 30, Butterfly Network announced that it secured FDA approval of its AI-powered handheld ultrasound tool for estimating gestation age. The company says this tool delivers results in […]